Physician profile
Akshay Goyal
NPI 1063890853
$4,085.79
in general payments reported to CMS, 2019-2025
7 companies · $39.61 in 2025
The $39.61 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $339 · 2021: $248 · 2022: $732 · 2023: $392 · 2024: $451 · 2025: $39.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,330.61 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $685.19 | 2019 | |
| Abbott Laboratories | $465.48 | 2020-2024 | Proclaim |
| Nevro Corp. | $430.72 | 2020-2024 | Senza |
| Spr Therapeutics, INC | $134.18 | 2024 | Sprint Pns System |
| Averitas Pharma INC. | $22.76 | 2025 | Qutenza |
| Medtronic, INC. | $16.85 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshay Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.